Engagement of the private pharmaceutical sector for TB control: rhetoric or reality?
Background Private-sector retail drug outlets are often the first point of contact for common health ailments, including tuberculosis (TB). Systematic reviews on public-private mix (PPM) interventions for TB did not perform in-depth reviews specifically on engaging retail drug outlets and related st...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2017-12-01
|
| Series: | Journal of Pharmaceutical Policy and Practice |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1186/s40545-016-0093-3 |
| _version_ | 1827593278844829696 |
|---|---|
| author | Niranjan Konduri Emily Delmotte Edmund Rutta |
| author_facet | Niranjan Konduri Emily Delmotte Edmund Rutta |
| author_sort | Niranjan Konduri |
| collection | DOAJ |
| description | Background Private-sector retail drug outlets are often the first point of contact for common health ailments, including tuberculosis (TB). Systematic reviews on public-private mix (PPM) interventions for TB did not perform in-depth reviews specifically on engaging retail drug outlets and related stakeholders in the pharmaceutical sector. Our objective was to better understand the extent to which the World Health Organization’s (WHO) recommendation on engaging retail drug outlets has been translated into programmatic policy, strategy, and intervention in low- and middle-income countries. Methods The study included a content analysis of global-level documents from WHO and the Stop TB Partnership in five phases. A country-level content analysis from four data sources was performed. Global-level findings were tabulated based on key messages related to engaging retail drug outlets. Country-level findings were analyzed based on four factors and tabulated. National strategic plans for TB control from 14 countries with varying TB burdens and a strong private sector were reviewed. Results 33 global-level documents and 77 full-text articles and Union World Lung Health conference abstracts were included for review. Based on experience of engaging retail drug outlets that has emerged since the mid-2000s, in 2011 WHO and the International Pharmaceutical Federation released a joint statement on promoting the engagement of national pharmacy associations in partnership with national TB programs. Only two of 14 countries’ national strategic plans had explicit statements on the need to engage their national pharmacy professional association. The success rate of referrals from retail drug outlets who visited an approved health facility for TB screening ranged from 48% in Vietnam to 86% in Myanmar. Coverage of retail drug outlets ranged from less than 5 to 9% of the universe of retail drug outlets. Conclusions For WHO’s End TB Strategy to be successful, scaling up retail drug outlets to increase national coverage, at least in countries with a thriving private sector, will be instrumental in accelerating the early detection and referral of the 3 million missing TB cases. The proposed PPM pharmacy model is applicable not only for TB control but also to tackle the antimicrobial resistance crisis in these countries. |
| first_indexed | 2024-03-09T02:08:06Z |
| format | Article |
| id | doaj.art-df231d95735749fc8130f33fc9383e1e |
| institution | Directory Open Access Journal |
| issn | 2052-3211 |
| language | English |
| last_indexed | 2024-03-09T02:08:06Z |
| publishDate | 2017-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Journal of Pharmaceutical Policy and Practice |
| spelling | doaj.art-df231d95735749fc8130f33fc9383e1e2023-12-07T15:28:01ZengTaylor & Francis GroupJournal of Pharmaceutical Policy and Practice2052-32112017-12-0110110.1186/s40545-016-0093-312315025Engagement of the private pharmaceutical sector for TB control: rhetoric or reality?Niranjan Konduri0Emily Delmotte1Edmund Rutta2Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, Management Sciences for Health,Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, Management Sciences for Health,Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, Management Sciences for Health,Background Private-sector retail drug outlets are often the first point of contact for common health ailments, including tuberculosis (TB). Systematic reviews on public-private mix (PPM) interventions for TB did not perform in-depth reviews specifically on engaging retail drug outlets and related stakeholders in the pharmaceutical sector. Our objective was to better understand the extent to which the World Health Organization’s (WHO) recommendation on engaging retail drug outlets has been translated into programmatic policy, strategy, and intervention in low- and middle-income countries. Methods The study included a content analysis of global-level documents from WHO and the Stop TB Partnership in five phases. A country-level content analysis from four data sources was performed. Global-level findings were tabulated based on key messages related to engaging retail drug outlets. Country-level findings were analyzed based on four factors and tabulated. National strategic plans for TB control from 14 countries with varying TB burdens and a strong private sector were reviewed. Results 33 global-level documents and 77 full-text articles and Union World Lung Health conference abstracts were included for review. Based on experience of engaging retail drug outlets that has emerged since the mid-2000s, in 2011 WHO and the International Pharmaceutical Federation released a joint statement on promoting the engagement of national pharmacy associations in partnership with national TB programs. Only two of 14 countries’ national strategic plans had explicit statements on the need to engage their national pharmacy professional association. The success rate of referrals from retail drug outlets who visited an approved health facility for TB screening ranged from 48% in Vietnam to 86% in Myanmar. Coverage of retail drug outlets ranged from less than 5 to 9% of the universe of retail drug outlets. Conclusions For WHO’s End TB Strategy to be successful, scaling up retail drug outlets to increase national coverage, at least in countries with a thriving private sector, will be instrumental in accelerating the early detection and referral of the 3 million missing TB cases. The proposed PPM pharmacy model is applicable not only for TB control but also to tackle the antimicrobial resistance crisis in these countries.http://dx.doi.org/10.1186/s40545-016-0093-3public-private mixtuberculosispharmacistsretail drug outletsprivate sectorpharmacy associations |
| spellingShingle | Niranjan Konduri Emily Delmotte Edmund Rutta Engagement of the private pharmaceutical sector for TB control: rhetoric or reality? Journal of Pharmaceutical Policy and Practice public-private mix tuberculosis pharmacists retail drug outlets private sector pharmacy associations |
| title | Engagement of the private pharmaceutical sector for TB control: rhetoric or reality? |
| title_full | Engagement of the private pharmaceutical sector for TB control: rhetoric or reality? |
| title_fullStr | Engagement of the private pharmaceutical sector for TB control: rhetoric or reality? |
| title_full_unstemmed | Engagement of the private pharmaceutical sector for TB control: rhetoric or reality? |
| title_short | Engagement of the private pharmaceutical sector for TB control: rhetoric or reality? |
| title_sort | engagement of the private pharmaceutical sector for tb control rhetoric or reality |
| topic | public-private mix tuberculosis pharmacists retail drug outlets private sector pharmacy associations |
| url | http://dx.doi.org/10.1186/s40545-016-0093-3 |
| work_keys_str_mv | AT niranjankonduri engagementoftheprivatepharmaceuticalsectorfortbcontrolrhetoricorreality AT emilydelmotte engagementoftheprivatepharmaceuticalsectorfortbcontrolrhetoricorreality AT edmundrutta engagementoftheprivatepharmaceuticalsectorfortbcontrolrhetoricorreality |